Published in Support Care Cancer on December 12, 2003
Etiology, endoscopic management and mortality of upper gastrointestinal bleeding in patients with cancer. United European Gastroenterol J (2013) 0.86
Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use. Pain (2000) 4.93
Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain (1995) 2.69
Pain treatment and outcomes for patients with advanced cancer who receive follow-up care at home. Cancer (1999) 1.77
Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study. Arch Intern Med (1996) 1.56
Corticosteroids and peptic ulceration. Palliat Med (1994) 1.21
Non-steroidal anti-inflammatory drugs and ulcer complications: a risk factor analysis for clinical decision-making. Scand J Gastroenterol (1996) 1.13
Nonsteroidal anti-inflammatory drugs and upper gastrointestinal bleeding, identifying high-risk groups by excess risk estimates. Scand J Gastroenterol (1995) 0.96
A long-term survey of morphine in cancer pain patients. J Pain Symptom Manage (1992) 0.96
Adrenal corticosteroid therapy in far-advanced cancer. Geriatrics (1972) 0.90
A cohort study (with re-sampled comparator groups) to measure the association between new NSAID prescribing and upper gastrointestinal hemorrhage and perforation. J Clin Epidemiol (1997) 0.84
Clinical aspects of upper gastrointestinal bleeding associated with the use of nonsteroidal antiinflammatory drugs. Am J Gastroenterol (1998) 0.78
Gastrointestinal bleeding in advanced cancer patients. J Pain Symptom Manage (2000) 0.75
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. Cancer Res (2007) 3.22
Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo. Blood (2003) 1.65
A five-year retrospective study of the epidemiological characteristics and visual outcomes of patients hospitalized for ocular trauma in a Mediterranean area. BMC Ophthalmol (2008) 1.49
Evaluation of esophageal motility using multichannel intraluminal impedance in healthy children and children with gastroesophageal reflux. J Pediatr Gastroenterol Nutr (2011) 1.49
The use of sublingual fentanyl for breakthrough pain by using doses proportional to opioid basal regimen. Curr Med Res Opin (2013) 1.47
Efficacy of periportal infiltration and intraperitoneal instillation of ropivacaine after laparoscopic surgery in children. J Laparoendosc Adv Surg Tech A (2009) 1.43
One-year outcomes with new-generation multifocal intraocular lenses. Ophthalmology (2008) 1.35
Deep sclerectomy versus punch trabeculectomy with or without phacoemulsification: a randomized clinical trial. J Glaucoma (2004) 1.16
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? Cancer Treat Rev (2010) 1.15
Management of painful bone metastases. Curr Opin Oncol (2007) 1.12
Palliative sedation in patients with advanced cancer followed at home: a systematic review. J Pain Symptom Manage (2011) 1.06
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain (2008) 1.04
Single nucleotide polymorphisms (SNPs) of pro-inflammatory/anti-inflammatory and thrombotic/fibrinolytic genes in patients with acute ischemic stroke in relation to TOAST subtype. Cytokine (2012) 1.04
Sleep disorders in advanced cancer patients: prevalence and factors associated. Support Care Cancer (2004) 1.03
KPC - 3 Klebsiella pneumoniae ST258 clone infection in postoperative abdominal surgery patients in an intensive care setting: analysis of a case series of 30 patients. BMC Anesthesiol (2013) 1.03
Deep sclerectomy versus trabeculectomy with low-dosage mitomycin C: four-year follow-up. Ophthalmologica (2008) 1.01
Surveillance of multidrug-resistant gram-negative bacilli in a neonatal intensive care unit: prominent role of cross transmission. Am J Infect Control (2007) 1.01
Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit. J Pain Symptom Manage (2009) 1.00
Is ranibizumab effective in stopping the loss of vision for choroidal neovascularisation in pathologic myopia? A long-term follow-up study. Br J Ophthalmol (2010) 0.99
Addition of a second opioid may improve opioid response in cancer pain: preliminary data. Support Care Cancer (2004) 0.98
Optimization of opioid therapy for preventing incident pain associated with bone metastases. J Pain Symptom Manage (2004) 0.97
The use of high doses of oxycodone in an acute palliative care unit. Am J Hosp Palliat Care (2010) 0.96
Opioid escalation in patients with cancer pain: the effect of age. J Pain Symptom Manage (2006) 0.95
Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review. J Pain Symptom Manage (2007) 0.95
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome. Clin Cancer Res (2008) 0.93
Cryptic Leishmania infantum infection in Italian HIV infected patients. BMC Infect Dis (2009) 0.93
Immuno-inflammatory predictors of stroke at follow-up in patients with chronic non-valvular atrial fibrillation (NVAF). Clin Sci (Lond) (2009) 0.92
Serum interleukin-6 in patients with metastatic bone disease: correlation with cystatin C. Med Oncol (2008) 0.92
Controlled sedation for refractory symptoms in dying patients. J Pain Symptom Manage (2008) 0.91
Tapentadol in cancer pain management: a prospective open-label study. Curr Med Res Opin (2012) 0.91
E-PTFE (Gore-Tex) implant with or without low-dosage mitomycin-C as an adjuvant in penetrating glaucoma surgery: 2 year randomized clinical trial. Acta Ophthalmol (2007) 0.90
Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose. J Pain Symptom Manage (2004) 0.90
Patients' and relatives' perceptions about intravenous and subcutaneous hydration. J Pain Symptom Manage (2005) 0.89
The long and winding road to useful predictive factors for anti-EGFR therapy in metastatic colorectal carcinoma: the KRAS/BRAF pathway. Oncology (2010) 0.89
Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine. J Pain Symptom Manage (2006) 0.87
Opioid-induced or pain relief-reduced symptoms in advanced cancer patients? Eur J Pain (2006) 0.87
Deep sclerectomy versus punch trabeculectomy: effect of low-dosage mitomycin C. Ophthalmologica (2005) 0.87
Serum follistatin in patients with prostate cancer metastatic to the bone. Clin Exp Metastasis (2010) 0.87
Peripheral frequency of CD4+ CD28- cells in acute ischemic stroke: relationship with stroke subtype and severity markers. Medicine (Baltimore) (2015) 0.87
Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids. Curr Med Res Opin (2013) 0.87
Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion. Cancer (2002) 0.87
Pattern and characteristics of advanced cancer patients admitted to hospices in Italy. Support Care Cancer (2012) 0.87
Dosing fentanyl buccal tablet for breakthrough cancer pain: dose titration versus proportional doses. Curr Med Res Opin (2012) 0.86
How do cancer patients receiving palliative care at home die? A descriptive study. J Pain Symptom Manage (2011) 0.86
Incidence of chronic pain in patients with end-stage renal disease on dialysis. J Pain Symptom Manage (2005) 0.86
Breakthrough pain in advanced cancer patients followed at home: a longitudinal study. J Pain Symptom Manage (2009) 0.86
Switching from transdermal drugs: an observational "N of 1" study of fentanyl and buprenorphine. J Pain Symptom Manage (2007) 0.86
Respiratory problems in advanced cancer. Support Care Cancer (2001) 0.85
Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis. Cancer (2009) 0.85
Rapid switching between transdermal fentanyl and methadone in cancer patients. J Clin Oncol (2005) 0.84
Emergencies in patients with advanced cancer followed at home. J Pain Symptom Manage (2012) 0.84
Celiac plexus block for pancreatic cancer pain: factors influencing pain, symptoms and quality of life. J Pain Symptom Manage (2003) 0.84
Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study. Clin J Pain (2010) 0.84
Opioid switching in patients with advanced cancer followed at home. A retrospective analysis. J Pain Symptom Manage (2012) 0.84
An Italian survey on the attitudes in treating breakthrough cancer pain in hospice. Support Care Cancer (2010) 0.84
The use of opioids for breakthrough pain in acute palliative care unit by using doses proportional to opioid basal regimen. Clin J Pain (2010) 0.84
Fentanyl buccal tablets for breakthrough pain in highly tolerant cancer patients: preliminary data on the proportionality between breakthrough pain dose and background dose. J Pain Symptom Manage (2011) 0.84
Breakthrough pain in oncology: a longitudinal study. J Pain Symptom Manage (2010) 0.83
Treatment strategies for cancer patients with breakthrough pain. Expert Opin Pharmacother (2009) 0.83
Prognostic factors of survival in patients with advanced cancer admitted to home care. J Pain Symptom Manage (2012) 0.83
Evaluation of esophageal motility and reflux in children treated for esophageal atresia with the use of combined multichannel intraluminal impedance and pH monitoring. J Pediatr Surg (2011) 0.83
Low doses of transdermal buprenorphine in opioid-naive patients with cancer pain: a 4-week, nonrandomized, open-label, uncontrolled observational study. Clin Ther (2009) 0.83
Bortezomib: a new pro-apoptotic agent in cancer treatment. Curr Cancer Drug Targets (2010) 0.82
The Liverpool Care Pathway for cancer patients dying in hospital medical wards: a before-after cluster phase II trial of outcomes reported by family members. Palliat Med (2013) 0.82
Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients. J Pain (2009) 0.82
Gastroesophageal reflux in young children treated for esophageal atresia: evaluation with pH-multichannel intraluminal impedance. J Pediatr Gastroenterol Nutr (2011) 0.82
Low morphine doses in opioid-naive cancer patients with pain. J Pain Symptom Manage (2006) 0.82
Randomized double-blind, double-dummy crossover clinical trial of oral tramadol versus rectal tramadol administration in opioid-naive cancer patients with pain. Support Care Cancer (2005) 0.81
Minor hepatic resection using heat coagulative necrosis. Am Surg (2009) 0.81
The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins. Thromb Res (2007) 0.81
Meaningful cut-off pain intensity for breakthrough pain changes in advanced cancer patients. Curr Med Res Opin (2012) 0.81
Tapentadol at medium to high doses in patients previously receiving strong opioids for the management of cancer pain. Curr Med Res Opin (2014) 0.81
Opioid use and effectiveness of its prescription at discharge in an acute pain relief and palliative care unit. Support Care Cancer (2013) 0.80
Outcome of opioid switching 4 weeks after discharge from a palliative care unit. Curr Med Res Opin (2011) 0.80
Lenograstim in preventing chemotherapy-induced febrile neutropenia in patients with soft tissue sarcoma. Anticancer Res (2013) 0.80
Food safety in hospital: knowledge, attitudes and practices of nursing staff of two hospitals in Sicily, Italy. BMC Health Serv Res (2007) 0.80
Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies. Curr Med Res Opin (2013) 0.80
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer. Cancer Chemother Pharmacol (2005) 0.80
Investigation and management of Toxoplasma gondii infection in pregnancy and infancy: a prospective study. Acta Pharmacol Sin (2011) 0.80
Prevention of venous thromboembolism in patients with cancer: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)(1). Thromb Res (2011) 0.80
Palliative sedation in advanced cancer patients followed at home: a retrospective analysis. J Pain Symptom Manage (2012) 0.80
Italian Oncological Pain Survey (IOPS): a multicentre Italian study of breakthrough pain performed in different settings. Clin J Pain (2015) 0.79